ABSTRACT
Context The coronavirus disease 2019 (COVID-19) outbreak is an unprecedented global public health challenge, leading to thousands of deaths every day worldwide. Despite the epidemiological importance, clinical patterns of children with COVID-19 remain unclear.
Objective To describe the clinical, laboratorial and radiological characteristics of children with COVID-19.
Data Sources The Medline database was searched between December 1st 2019 and March 30th 2020.
Study Selection Inclusion criteria were: (1) studied patients younger than 18 years old; presented original data from cases of COVID-19 confirmed by reverse-transcription polymerase chain reaction; and (3) contained descriptions of clinical manifestations, laboratory tests or radiological examinations.
Data Extraction Number of cases, gender, age, clinical manifestations, laboratory tests, radiological examinations and outcomes.
Results A total of 34 studies (1,118 cases) were included. From all the cases, 1,111 had their severity classified: 14.3% were asymptomatic, 36.4% were mild, 46.0% were moderate, 2.2% were severe and 1.2% were critical. The most prevalent symptom was fever (16.3%), followed by cough (14.4%), nasal symptoms (3.6%), diarrhea (2.7%) and nausea/vomiting (2.5%). One hundred forty-five (12.9%) children were diagnosed with pneumonia and 43 (3.8%) upper airway infections were reported. Reduced lymphocyte count were reported in 13.1% of cases. Abnormalities on computed tomography were reported in 62.7% of cases. The most prevalent abnormalities reported were ground glass opacities, patchy shadows and consolidations. Only one death was reported.
Conclusions Clinical manifestations of children with COVID-19 differ widely from adults cases. Fever and respiratory symptoms should not be considered a hallmark of COVID-19 in children.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding for this manuscript.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Source: No external funding for this manuscript.
Financial Disclosure: The authors have no financial relationships relevant to this study to disclose.
Conflict of Interest: The authors have disclosed that they do not have any potential conflicts of interest.
Tiago Henrique de Souza conceptualized and designed the study, drafted the initial manuscript, and reviewed and revised the manuscript.
Tiago Henrique de Souza and José Antonio Hersan Nadal designed the data collection instruments, collected data, carried out the initial analyses, and reviewed and revised the manuscript.
Roberto José Negrão Nogueira, Ricardo Mendes Pereira and Marcelo Barciela Brandão coordinated and supervised data collection, and critically reviewed the manuscript for important intellectual content.
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Data Availability
All relevant data are described in the manuscript.
Abbreviations
- WHO
- World Health Organization
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- COVID-19
- Coronavirus disease 2019
- CT
- Computed tomography
- CDC
- Centers for Disease Control and Prevention
